Abbott Laboratories (NYSE:ABT)

An analysis of the common-size income statement reveals a period of relative stability in gross margins, contrasted by significant volatility in operating expenses and a notable non-recurring tax event. While top-line efficiency remained consistent for much of the period, recent quarters indicate mounting pressure on operating margins due to rising administrative costs.

Gross Profitability and Cost Structure

Gross profit margins generally fluctuated between 49% and 54%. The cost of products sold, excluding amortization, remained largely stable, typically ranging between 42% and 45% of net sales. Amortization of intangible assets remained a consistent drag on gross margins, averaging approximately 4% to 5%, although a slight downward trend was observed between 2022 and 2025 before an increase to 5.23% in June 2026.

Operating Expense Trends

Research and development expenditures remained highly disciplined, consistently representing between 6% and 7.5% of net sales, indicating a steady commitment to innovation regardless of fluctuations in other expense categories. In contrast, selling, general, and administrative (SG&A) expenses exhibited significant volatility. After reaching a low of 23.43% in March 2022, SG&A costs trended upward, peaking at 33.50% in March 2026. This increase in administrative overhead is the primary driver behind the compression of operating earnings in the latter part of the observed period.

Operating and Pre-Tax Earnings

Operating earnings showed a cyclical pattern, peaking at 24.48% in early 2022 before settling into a range of 15% to 19% through 2025. A sharp decline is evident in the first half of 2026, with operating earnings falling to 12.05% and 13.44%, correlating directly with the spike in SG&A expenses. Interest expenses remained relatively low and stable around 1% to 1.5% for most of the period, though a notable increase to 2.79% occurred in June 2026.

Taxation and Net Earnings Anomaly

Net earnings typically fluctuated between 10% and 20% of net sales. However, a significant outlier occurred on December 31, 2024, where taxes on earnings were recorded as a positive 65.60% of net sales, resulting in a net earnings spike of 84.10%. This suggests a substantial one-time tax benefit or accounting adjustment. Excluding this anomaly, the trend for net earnings in 2026 shows a downward trajectory, reaching a period low of 7.37% by June 2026.

The overall financial trajectory indicates that while the company maintains a strong gross profit baseline, operating efficiency has deteriorated recently. The convergence of increased SG&A costs and rising interest expenses in 2026 has led to a marked reduction in the percentage of net sales converted into net income.